Quantcast

Latest DNA vaccination Stories

2014-08-14 12:28:24

DALLAS, August 14, 2014 /PRNewswire/ -- LifeScienceIndustryResearch.com offers Animal/Veterinary Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global Forecast to 2018 research report in its store. It says global animal vaccines market is in its growth phase and is poised to cross the $8 billion mark by...

2014-08-05 08:35:43

WELLESLEY, Massachusetts, August 5, 2014 /PRNewswire/ -- BCC Research [http://www.bccresearch.com ] (http://www.bccresearch.com) reveals in its new report, DNA VACCINES: TECHNOLOGIESAND GLOBAL MARKETS [http://www.bccresearch.com/market-research/biotechnology/dna-vaccines-bio067b.html ], the global market for DNA vaccines is expected to grow to $2.7 billion by 2019, with a five-year compound annual growth rate (CAGR) of 54.8%. The clinical vaccines category, the largest and...

2014-06-23 04:20:45

Inovio's Immunotherapy will Treat Women with Inoperable HPV-caused Cancer BLUE BELL, Pa., June 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity, clinical responses and disease-free survival of its DNA immunotherapy product, INO-3112, in treating human papillomavirus (HPV)-associated cervical cancer. INO-3112 is a combination of Inovio's lead active immunotherapy...

2014-06-16 04:21:37

BLUE BELL, Pa., June 16, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President & CEO, Dr. J. Joseph Kim, will participate in a panel at the Piper Jaffray GenomeRx Symposium on June 23 to discuss Inovio's leadership in the advancement of novel DNA-based immune therapies. Inovio management will also present a corporate overview at the 2014 BIO International Convention hosted by the Biotechnology Industry Organization (BIO). This year's...

2014-05-30 04:22:21

BLUE BELL, Pa., May 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014. The common stock will continue to trade under the symbol "INO." As filed on May 22, 2014, the Company's stockholders approved the proposal of a reverse...

2014-05-27 04:21:46

BLUE BELL, Pa., May 27, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its 90%-owned subsidiary, VGX Animal Health, Inc. (VAH), has concluded an agreement for the sale of its animal health assets to Plumbline Life Sciences, Inc. (PLS) of Korea. The assets being transferred include an exclusive license with Inovio for animal applications of its growth hormone-releasing hormone (GHRH) technology and animal DNA vaccines plus a non-exclusive license...

2014-05-27 04:21:43

Protection Data Presented at the 17th Annual Meeting of the American Society of Gene & Cell Therapy BLUE BELL, Pa., May 27, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its novel DNA-based therapeutic monoclonal antibody targeting Chikungunya virus (CHIKV) completely protected mice from a lethal CHIKV challenge. In this preclinical study, a prototype DNA plasmid construct encoding for a monoclonal antibody for CHIKV envelope protein was...

2014-05-23 04:20:51

BLUE BELL, Pa., May 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that at the Company's Annual General Meeting held May 22, 2014, the Company's shareholders approved the proposal of a reverse split of the Company's common stock. The Company's Board of Directors subsequently approved the immediate implementation of a 1-for-4 reverse stock split of Inovio's common stock, where each 4 shares of issued and outstanding common stock and equivalents...

2014-05-21 04:21:27

BLUE BELL, Pa., May 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. Joseph Kim, President and CEO, will give a corporate presentation at the Jefferies 2014 Global Healthcare Conference taking place June 2-5 at the Grand Hyatt Hotel in New York City. Inovio PresentationMonday, June 2, 20148:00 AM ET A live webcast of Dr. Kim's presentation can be accessed at the following URL: http://wsw.com/webcast/jeff82/INO. An archived version of...

2014-05-19 23:07:53

Dr. William Hearl will discuss the missing link in enhancing the effectiveness of DNA vaccines in a panel discussion on Wednesday, May 21 hosted by Ed Butler of the BBC Hershey, PA & Rockville, MD (PRWEB) May 19, 2014 Immunomic Therapeutics, Inc. (ITI), a vaccine pioneer in the biotechnology industry, is proud to announce that the company’s CEO, Dr. William G. Hearl, will be a featured panelist at the prestigious Future in Review (FiRe) Conference hosted by Strategic News Service...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related